Browse by Medical Category
Accepting New Patients
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Analysis of circulating tumor cells in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.
A team of physicians and physicists are collaborating on a mission to solve the riddle of pancreatic cancer, one of medicine’s most lethal malignancies. The pancreatic-cancer convergence team has a plan to mount a clinical trial to test a new hypothesis: that treatment with synthetic vitamin D can make treatment-resistant pancreas tumors vulnerable to a patient’s immune system. David T. Ting, MD, a medical oncologist at Massachusetts General Hospital Cancer Center, is part of this innovative approach to fight pancreatic cancer.
Back to Top